RxSight, Inc.
RxSight, Inc. (RXST) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · RXST · as of Jun 8, 2026
Activity summary
Buy transactions
6
P-Purchase only
Sell transactions
32
12 Months
Buy/Sell ratio
0.19
Buy/Sell (by trades)
Overall sentiment
RxSight, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
RXST insider buying and selling by quarter
RXST insider selling · RXST insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · RXST ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
RXST executive sell shares · RXST board member insider trading · RXST insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Apr 17, 2026 | Goldshleger Ilya COO | Option | 12,489 | $52K | Form 4 |
| Feb 28, 2026 | Wilterding Mark CFO | Option | 20,441 | — | Form 4 |
| Feb 28, 2026 | Wilterding Mark CFO | Other | 8,068 | $61K | Form 4 |
| Feb 28, 2026 | Gaines Scott Chief Customer Officer | Option | 6,261 | — | Form 4 |
| Feb 28, 2026 | Gaines Scott Chief Customer Officer | Other | 2,580 | $20K | Form 4 |
| Sep 25, 2025 | Goldshleger Ilya See remarks | Option | 8,349 | $34K | Form 4 |
| Sep 25, 2025 | Goldshleger Ilya See remarks | Option | 15,096 | $66K | Form 4 |
| Jul 31, 2025 | COHEN RAYMOND W Director | Award | 35,668 | — | Form 4 |
| Jun 3, 2025 | LINK WILLIAM J PHD Director | Award | 10,752 | — | Form 4 |
| Jun 3, 2025 | Fountain Tamara Director | Award | 10,752 | — | Form 4 |
| Jun 3, 2025 | Warner Robert Keith Director | Award | 10,752 | — | Form 4 |
| Jun 3, 2025 | Maniar Shweta Director | Award | 10,752 | — | Form 4 |
| Jun 3, 2025 | PALMISANO ROBERT J Director | Award | 10,752 | — | Form 4 |
| Jun 3, 2025 | Andrews Julie Director | Award | 10,752 | — | Form 4 |
| Jun 3, 2025 | Tammenoms Bakker Juliet Director | Award | 10,752 | — | Form 4 |
| Jun 3, 2025 | Corley Jesse Anderson Director | Award | 10,752 | — | Form 4 |
| Jun 2, 2025 | Weinberg Eric See remarks | Option | 188,002 | $739K | Form 4 |
| Apr 14, 2025 | Thunen Shelley B See remarks | Option | 7,792 | $34K | Form 4 |
| Mar 12, 2025 | Fountain Tamara Director | Sale | 7,000 | $180K | Form 4 |
| Jan 22, 2025 | Maniar Shweta Director | Sale | 3,519 | $109K | Form 4 |
| Jan 16, 2025 | Corley Jesse Anderson Director | Purchase | 1,767 | $55K | Form 4 |
| Jan 15, 2025 | Corley Jesse Anderson Director | Purchase | 1,443 | $45K | Form 4 |
| Nov 29, 2024 | Goldshleger Ilya See remarks | Option | 3,105 | $47K | Form 4 |
| Nov 29, 2024 | Goldshleger Ilya See remarks | Sale | 3,105 | $143K | Form 4 |
| Nov 26, 2024 | Maniar Shweta Director | Sale | 3,782 | $174K | Form 4 |
Gaines Scott
Chief Customer Officer
Date
Feb 28
Shares
2,580
Price
$7.61
Value
$20K
Corley Jesse Anderson
Director
Date
Jan 16
Shares
1,767
Price
$31.13
Value
$55K
Corley Jesse Anderson
Director
Date
Jan 15
Shares
1,443
Price
$31.18
Value
$45K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About RXST insider trading
RXST insider trades
RxSight, Inc. (RXST) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Goldshleger Ilya (COO), Wilterding Mark (CFO), Gaines Scott (Chief Customer Officer). Over the past 12 months, 4 insiders have filed transactions with the SEC. RXST insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For RxSight, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
RXST insider trading · 5 questionsThe insiders of RxSight, Inc. (RXST) include executives and directors such as Goldshleger Ilya (COO), Wilterding Mark (CFO), Gaines Scott (Chief Customer Officer), among others. Over the past 12 months, 4 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026